硕世生物净利连亏3年 2019年IPO募7亿招商证券保荐

Core Viewpoint - Shuoshi Bio (688399.SH) reported a decline in revenue and an increase in net losses for the fiscal year 2025, indicating ongoing financial challenges for the company [1]. Financial Performance Summary - The total operating revenue for 2025 was 340.38 million yuan, a decrease of 2.64% compared to the previous year [2]. - The operating profit was -30.89 million yuan, a significant decline from a profit of 8.81 million yuan in the previous year, representing a change of -450.49% [2]. - The total profit was -31.62 million yuan, down from a profit of 0.42 million yuan in the previous year, marking a change of -855.06% [2]. - The net profit attributable to shareholders was -39.71 million yuan, worsening from a loss of 0.20 million yuan in the previous year [2]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was -103.83 million yuan, an increase in loss from -71.84 million yuan in the previous year [2]. Cash Flow and Other Metrics - The net cash flow from operating activities was 146 million yuan, showing a significant increase of 228.97% year-on-year [3]. - In 2024, the company achieved an operating revenue of 350 million yuan, a decrease of 13.29% compared to the previous year [3]. - The net profit attributable to shareholders for 2024 was -0.20 million yuan, an improvement from -37.4 million yuan in the previous year [3]. - The net profit attributable to shareholders after deducting non-recurring gains and losses for 2024 was -71.84 million yuan, compared to -429.20 million yuan in the previous year [3]. Company Background - Shuoshi Bio was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on December 5, 2019, with an initial issuance of 14.66 million shares at a price of 46.78 yuan per share [4]. - The total funds raised from the initial public offering amounted to 685.79 million yuan, with net proceeds of 612.93 million yuan, exceeding the original plan by 210.28 million yuan [4]. - The company intended to use the raised funds for the construction of its headquarters industrial park in Taizhou [4].